Files in this item



application/pdfYIN-DISSERTATION-2015.pdf (6MB)
(no description provided)PDF


Title:Fighting cancer with nanomedicine−drug-polyester nanoconjugates for targeted cancer therapy
Author(s):Yin, Qian
Director of Research:Cheng, Jianjun
Doctoral Committee Chair(s):Cheng, Jianjun
Doctoral Committee Member(s):Fan, Timothy M.; Braun, Paul V.; Lu, Yi; Kilian, Kristopher A.
Department / Program:Materials Science & Engineerng
Discipline:Materials Science & Engr
Degree Granting Institution:University of Illinois at Urbana-Champaign
Cancer Therapy
Cancer diagnosis
Cancer targeting
Molecular imaging
Abstract:The aim of my Ph. D. research is to develop drug-polyester nanoconjugates (NCs) as a novel translational polymeric drug delivery system that can successfully evade non-specific uptake by reticuloendothelial system (RES) and facilitate targeted cancer diagnosis and therapy. By uniquely integrating well-established chemical reaction-controlled ring opening polymerization (ROP) with nanoprecipitation technique, I successfully developed a polymeric NC system based on poly(lactic acid) and poly(O-carboxyanhydrides) (OCA) that allows for the quantitative loading and controlled release of a variety of anticancer drugs. The developed NC system could be easily modified with parmidronate, one of bisphosphonates commonly used as the treatment for disease characterized by osteolysis, to selectively deliver doxorubicin (Doxo) to the bone tissues and substantially to improve their therapeutic efficiency in inhibiting the growth of osteosarcoma in both murine and canine models. More importantly, the developed NCs could avidly bind to human serum albumin, a ubiquitous protein in the blood, to bypass the endothelium barrier and penetrate into tumor tissues more deeply and efficiently. When compared with PEGylated NCs, these albumin-bound NCs showed significantly reduced accumulation in RES and enhanced tumor accumulation, which consequently contributed to higher their tumor inhibition capabilities. In addition, the developed NC system allows easy incorporation of X-ray computed tomography (CT) contrast agents to largely facilitate personalized therapy by improving diagnosis accuracy and monitoring therapeutic efficacy. Through the synthetic and formulation strategy I developed, a large quantity (grams or larger-scale) of drug-polyester NCs can be easily obtained, which can be used as a model drug delivery system for fundamental studies as well as a real drug delivery system for disease treatment in clinical settings.
Issue Date:2015-07-01
Rights Information:Copyright 2015 Qian Yin
Date Available in IDEALS:2015-09-29
Date Deposited:August 201

This item appears in the following Collection(s)

Item Statistics